Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models

International Journal of Molecular Sciences(2024)10.3390/ijms252313160Source: DataRank Database

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.80)OA: goldTopics (28)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hector Esquer ORCID,Timothy Kellett ORCID,Sophia Clune ORCID,Paul Awolade ORCID,Laura A. Pike ORCID

Live enrichment

PubMed:39684869 OpenAlex:https://openalex.org/W4405197633

NIH NCI

Grant: R01-CA251361

NIH NCI

Grant: P30-CA046934

FWCI

0.80

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/25/23/13160/pdf?version=1733548991

publisherhttps://www.mdpi.com/1422-0067/25/23/13160/pdf?version=1733548991

publisherhttps://www.mdpi.com/1422-0067/25/23/13160/pdf

journalhttps://doi.org/10.3390/ijms252313160

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39684869

Fields of Study

Cancer therapeutics and mechanismsPARP inhibition in cancer therapyDrug Transport and Resistance Mechanisms

MeSH Terms

IrinotecanOxaliplatinAnimalsAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDisease Models, AnimalDNA DamageDNA HelicasesDNA-Binding ProteinsDrug SynergismFemaleFluorouracilHumansColorectal NeoplasmsXenograft Model Antitumor AssaysCell Line, TumorMice

Keywords

Colorectal cancerChemotherapyCancer researchMedicineCancerOncologyPharmacologyInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being